Skip to main content

Table 1 Patient demographics and tumor characteristics

From: One-and-a-half nostril endoscopic transsphenoidal approach for pituitary adenomas—a technical report

Patient age, mean ± SD, y

49.7 ± 14.1

Male/female, n

35/22

Follow up (range), mo

18 (6–24)

Tumor with volumes mm3

22*20*20

Recurrent, n (%)

7 (12.3%)

Presenting symptoms, n (%)

 Abnormal visual functions

32 (56%)

 Endocrinopathy

18 (32%)

 Headache

13 (23%)

 Incidental

7 (12%)

 Pituitary apoplexy

6 (11%)

Knosp score, n (%)

 0

3 (5.3%)

 1

8 (14.0%)

 2

16 (28.1%)

 3

19 (33.3%)

 4

11 (19.3%)

Nonfunctioning adenoma, n (%)

39 (68.4%)

Functioning adenoma, n (%)

18 (31.6%)

Growth hormone

12 (21.1%)

Prolactinomas

4 (7.0%)

ACTH

2 (3.5%)